Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Qianhe Xu & Junmin Zhang. (2022) Novel strategies for targeting the thioredoxin system for cancer therapy. Expert Opinion on Drug Discovery 17:5, pages 437-442.
Read now
Read now
Evgeny Chupakhin & Mikhail Krasavin. (2021) Thioredoxin reductase inhibitors: updated patent review (2017-present). Expert Opinion on Therapeutic Patents 31:8, pages 745-758.
Read now
Read now
Jianqiang Xu & Jianguo Fang. (2021) How can we improve the design of small molecules to target thioredoxin reductase for treating cancer?. Expert Opinion on Drug Discovery 16:4, pages 331-333.
Read now
Read now
Anna Jastrząb & Elżbieta Skrzydlewska. (2021) Thioredoxin-dependent system. Application of inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 362-371.
Read now
Read now
Mikhail Krasavin, Tatiana Sharonova, Vladimir Sharoyko, Daniil Zhukovsky, Stanislav Kalinin, Raivis Žalubovskis, Tatiana Tennikova & Claudiu T. Supuran. (2020) Combining carbonic anhydrase and thioredoxin reductase inhibitory motifs within a single molecule dramatically increases its cytotoxicity. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 665-671.
Read now
Read now
Mikhail Krasavin, Raivis Žalubovskis, Aiga Grandāne, Ilona Domračeva, Petr Zhmurov & Claudiu T. Supuran. (2020) Sulfocoumarins as dual inhibitors of human carbonic anhydrase isoforms IX/XII and of human thioredoxin reductase. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 506-510.
Read now
Read now
Jianming Liao, Linlin Wang, Zhongxi Wu, Zhixiang Wang, Jun Chen, Yucheng Zhong, Feng Jiang & Yuanyuan Lu. (2019) Identification of phenazine analogue as a novel scaffold for thioredoxin reductase I inhibitors against Hep G2 cancer cell lines. Journal of Enzyme Inhibition and Medicinal Chemistry 34:1, pages 1158-1163.
Read now
Read now
Olga Bakulina, Anton Bannykh, Mirna Jovanović, Ilona Domračeva, Ana Podolski-Renić, Raivis Žalubovskis, Milica Pešić, Dmitry Dar’in & Mikhail Krasavin. (2019) Design, synthesis, and biological evaluation of novel derivatives of dithiodiglycolic acid prepared via oxidative coupling of thiols. Journal of Enzyme Inhibition and Medicinal Chemistry 34:1, pages 665-671.
Read now
Read now
Articles from other publishers (62)
Qiuyan Ban, Wenjing Chi, Xiaoxiao Wang, Shiqiong Wang, Dan Hai, Guangshan Zhao, Qiuyan Zhao, Daniel Granato & Xianqing Huang. (2023) (-)-Epigallocatechin-3-Gallate Attenuates the Adverse Reactions Triggered by Selenium Nanoparticles without Compromising Their Suppressing Effect on Peritoneal Carcinomatosis in Mice Bearing Hepatocarcinoma 22 Cells. Molecules 28:9, pages 3904.
Crossref
Crossref
Ilya A. Shutkov, Yulia N. Okulova, Dmitrii M. Mazur, Nikolai A. Melnichuk, Denis A. Babkov, Elena V. Sokolova, Alexander A. Spasov, Elena R. Milaeva & Alexey A. Nazarov. (2023) New Organometallic Ru(II) Compounds with Lonidamine Motif as Antitumor Agents. Pharmaceutics 15:5, pages 1366.
Crossref
Crossref
Ji Zhou, Li-Zhen Yu, Ya-Li Fan, Ci-Hao Guo, Xiao-Mei Lv, Zhi-Yin Zhou, Hui-Dan Huang, Dong-Dong Miao, Sheng-Peng Zhang, Xin-Yu Li, Ping-Ping Zhao, Xiao-Ping Liu, Wei-Hua Hu & Chao Zhang. (2023) Discovery of novel hydroxyamidine based indoleamine 2,3-dioxygenase 1 (IDO1) and thioredoxin reductase 1 (TrxR1) dual inhibitors. European Journal of Medicinal Chemistry 245, pages 114860.
Crossref
Crossref
Yunlong Lu, Wan Zhang, Jing Shi, Yawen Wang & Wukun Liu. 2023. Privileged Scaffolds in Drug Discovery. Privileged Scaffolds in Drug Discovery
901
914
.
Li Ding, Jianyu Yan, Tengfei Li, Zhenyuan Miao, Huanhai Liu & Chunlin Zhuang. 2023. Privileged Scaffolds in Drug Discovery. Privileged Scaffolds in Drug Discovery
41
63
.
Wei Xiang Koh, Jia Li Fong, Ping Xuan Goh, Andrea Paris Gomez, Zhen Xuan Wong & Weng Kee Leong. (2022) Photochemical reactions of dinuclear organometallic complexes with diphenyl dichalcogenides. Journal of Organometallic Chemistry 982, pages 122517.
Crossref
Crossref
Jooyoung Lee, Jiye Kim, Ryunjin Lee, Eunkyeong Lee, Tae Gyu Choi, Amy Sinyoung Lee, Young-In Yoon, Gil-Chun Park, Jung-Man Namgoong, Sung-Gyu Lee & Eunyoung Tak. (2022) Therapeutic strategies for liver diseases based on redox control systems. Biomedicine & Pharmacotherapy 156, pages 113764.
Crossref
Crossref
Qianhe Xu, Junmin Zhang, Zhengjia Zhao, Yajun Chu & Jianguo Fang. (2022) Revealing PACMA 31 as a new chemical type TrxR inhibitor to promote cancer cell apoptosis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1869:10, pages 119323.
Crossref
Crossref
Surupa Chakraborty, Esha Sircar, Camelia Bhattacharyya, Ankita Choudhuri, Akansha Mishra, Sreejita Dutta, Sneha Bhatta, Kumar Sachin & Rajib Sengupta. (2022) S-Denitrosylation: A Crosstalk between Glutathione and Redoxin Systems. Antioxidants 11:10, pages 1921.
Crossref
Crossref
Radosveta Gencheva, Qing Cheng & Elias S.J. Arnér. (2022) Thioredoxin reductase selenoproteins from different organisms as potential drug targets for treatment of human diseases. Free Radical Biology and Medicine 190, pages 320-338.
Crossref
Crossref
Junmin Zhang, Xinming LiZhengjia ZhaoWenqing CaiJianguo Fang. (2022) Thioredoxin Signaling Pathways in Cancer. Antioxidants & Redox Signaling.
Crossref
Crossref
Zhongren Xu, Jianqiang Xu, Shibo Sun, Wei Lin, Yongming Li, Qiuyue Lu, Fuwei Li, Zhibin Yang, Yunlong Lu & Wukun Liu. (2022) Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma. Redox Biology 54, pages 102351.
Crossref
Crossref
Haoliang Li, Renhao Jiang, Lejing Lou, Chao Jia, Linfang Zou & Mochuan Chen. (2022) Formononetin Improves the Survival of Random Skin Flaps Through PI3K/Akt-Mediated Nrf2 Antioxidant Defense System. Frontiers in Pharmacology 13.
Crossref
Crossref
Iogann Tolbatov & Alessandro Marrone. (2022) Selenocysteine of thioredoxin reductase as the primary target for the antitumor metallodrugs: A computational point of view. Journal of Organometallic Chemistry 965-966, pages 122330.
Crossref
Crossref
Jan G. Felber, Lena Poczka, Karoline C. Scholzen, Lukas Zeisel, Martin S. Maier, Sander Busker, Ulrike Theisen, Christina Brandstädter, Katja Becker, Elias S. J. Arnér, Julia Thorn-Seshold & Oliver Thorn-Seshold. (2022) Cyclic 5-membered disulfides are not selective substrates of thioredoxin reductase, but are opened nonspecifically. Nature Communications 13:1.
Crossref
Crossref
Raghavendra S. Patwardhan, Deepak Sharma & Santosh K. Sandur. (2022) Thioredoxin reductase: An emerging pharmacologic target for radiosensitization of cancer. Translational Oncology 17, pages 101341.
Crossref
Crossref
E. G. Chupakhin & M. Yu. Krasavin. (2022) Natural compounds as inhibitors of thioredoxin reductase (TrxR1). Russian Chemical Bulletin 71:3, pages 443-448.
Crossref
Crossref
Dongguo Xia, Hao Liu, Xiang Cheng, Manikantha Maraswami, Yiting Chen & Xianhai Lv. (2022) Recent Developments of Coumarin-based Hybrids in Drug Discovery. Current Topics in Medicinal Chemistry 22:4, pages 269-283.
Crossref
Crossref
Junmin Zhang, Qianhe Xu & Di Ma. (2022) Inhibition of thioredoxin reductase by natural anticancer candidate β-lapachone accounts for triggering redox activation-mediated HL-60 cell apoptosis. Free Radical Biology and Medicine 180, pages 244-252.
Crossref
Crossref
Radosveta GenchevaElias S.J. Arnér. (2022) Thioredoxin Reductase Inhibition for Cancer Therapy. Annual Review of Pharmacology and Toxicology 62:1, pages 177-196.
Crossref
Crossref
Jun Yan, Yuzhu Xu, Xing Jin, Qiaoxuan Zhang, Feng Ouyang, Liqiao Han, Min Zhan, Xingshu Li, Baoxia Liang & Xianzhang Huang. (2022) Structure modification and biological evaluation of indole-chalcone derivatives as anti-tumor agents through dual targeting tubulin and TrxR. European Journal of Medicinal Chemistry 227, pages 113897.
Crossref
Crossref
Wei Ye, Taomei Liu, Weiyang Zhang & Weimin Zhang. (2021) The Toxic Mechanism of Gliotoxins and Biosynthetic Strategies for Toxicity Prevention. International Journal of Molecular Sciences 22:24, pages 13510.
Crossref
Crossref
Ilya A. Shutkov, Yulia N. Okulova, Vladimir Yu. Tyurin, Elena V. Sokolova, Denis A. Babkov, Alexander A. Spasov, Yulia A. Gracheva, Claudia Schmidt, Kirill I. Kirsanov, Alexander A. Shtil, Olga M. Redkozubova, Elena F. Shevtsova, Elena R. Milaeva, Ingo Ott & Alexey A. Nazarov. (2021) Ru(III) Complexes with Lonidamine-Modified Ligands. International Journal of Molecular Sciences 22:24, pages 13468.
Crossref
Crossref
Geir Bjørklund, Lili Zou, Jun Wang, Christos T. Chasapis & Massimiliano Peana. (2021) Thioredoxin reductase as a pharmacological target. Pharmacological Research 174, pages 105854.
Crossref
Crossref
Mengdi Li, Wanpeng Cheng & Lantian Zhang. (2021) Maternal selenium deficiency suppresses proliferation, induces autophagy dysfunction and apoptosis in the placenta of mice. Metallomics 13:11.
Crossref
Crossref
Zi-Long Song, Junmin Zhang, Qianhe Xu, Danfeng Shi, Xiaojun Yao & Jianguo Fang. (2021)
Structural Modification of Aminophenylarsenoxides Generates Candidates for Leukemia Treatment
via
Thioredoxin Reductase Inhibition
. Journal of Medicinal Chemistry 64:21, pages 16132-16146.
Crossref
Crossref
Sheelarani Karunanithi, Ruifu Liu, Yongchun Hou, Giancarlo Gonzalez, Natasha Oldford, Anne Jessica Roe, Nethrie Idipilly, Kalpana Gupta, Chandra Sekhar Amara, Satwikreddy Putluri, Grace Kyueun Lee, Juan Valentin-Goyco, Lindsay Stetson, Stephen A. Moreton, Vasanta Putluri, Shyam M. Kavuri, Yogen Saunthararajah, Marcos de Lima, Gregory P. Tochtrop, Nagireddy Putluri & David N. Wald. (2021) Thioredoxin reductase is a major regulator of metabolism in leukemia cells. Oncogene 40:33, pages 5236-5246.
Crossref
Crossref
Junmin Zhang, Qianhe Xu, Hong-Ying Yang, Minghao Yang, Jianguo Fang & Kun Gao. (2021) Inhibition of Thioredoxin Reductase by Santamarine Conferring Anticancer Effect in HeLa Cells. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Dana M. Zaher, Wafaa S. Ramadan, Raafat El-Awady, Hany A. Omar, Fatema Hersi, Vunnam Srinivasulu, Ibrahim Y. Hachim, Farah I. Al-Marzooq, Cijo G. Vazhappilly, Salim Merali, Carmen Merali, Nelson C. Soares, Paul Schilf, Saleh M. Ibrahim & Taleb H. Al-Tel. (2021) A Novel Benzopyrane Derivative Targeting Cancer Cell Metabolic and Survival Pathways. Cancers 13:11, pages 2840.
Crossref
Crossref
Dmitry Dar'in, Grigory Kantin, Evgeny Chupakhin, Vladimir Sharoyko & Mikhail Krasavin. (2021)
Natural‐Like Spirocyclic Δ
α,β
‐Butenolides Obtained from Diazo Homophthalimides
. Chemistry – A European Journal 27:31, pages 8221-8227.
Crossref
Crossref
Junmin ZhangDongzhu DuanAlsiddig OsamaJianguo Fang. (2021) Natural Molecules Targeting Thioredoxin System and Their Therapeutic Potential. Antioxidants & Redox Signaling 34:14, pages 1083-1107.
Crossref
Crossref
Yuning Liu, Yanan Yu, Qingshi Meng, Xueting Jia, Jiawei Zhu, Chaohua Tang, Qingyu Zhao, Xiaohui Feng & Junmin Zhang. (2021) A Fluorescent Probe for the Specific Staining of Cysteine Containing Proteins and Thioredoxin Reductase in SDS-PAGE. Biosensors 11:5, pages 132.
Crossref
Crossref
Marzieh Sohrabi, Mina Saeedi, Bagher Larijani & Mohammad Mahdavi. (2021) Recent advances in biological activities of rhodium complexes: Their applications in drug discovery research. European Journal of Medicinal Chemistry 216, pages 113308.
Crossref
Crossref
Lina Bu, Yingxuan Tian, Hongqing Wen, Weihong Jia & Shuanying Yang. (2021) miR-195-5p exerts tumor-suppressive functions in human lung cancer cells through targeting TrxR2. Acta Biochimica et Biophysica Sinica 53:2, pages 189-200.
Crossref
Crossref
Yuning Liu, Yanan Yu, Qingyu Zhao, Chaohua Tang, Huiyan Zhang, Yuchang Qin, Xiaohui Feng & Junmin Zhang. (2021) Fluorescent probes based on nucleophilic aromatic substitution reactions for reactive sulfur and selenium species: Recent progress, applications, and design strategies. Coordination Chemistry Reviews 427, pages 213601.
Crossref
Crossref
Sander Busker, Brent Page & Elias S.J. Arnér. (2020) To inhibit TrxR1 is to inactivate STAT3–Inhibition of TrxR1 enzymatic function by STAT3 small molecule inhibitors. Redox Biology 36, pages 101646.
Crossref
Crossref
Yang Zhang, Jiabei Zhou, Qin Ye, Kui Zeng, Jie Pan, Lu Chen, Yingying Wang, Bo Yang, Qiaojun He, Jianqing Gao, Su Zeng & Lushan Yu. (2020) 6-Dithio-2′-deoxyguanosine analogs induce reactive oxygen species-mediated tumor cell apoptosis via bi-targeting thioredoxin 1 and telomerase. Toxicology and Applied Pharmacology 401, pages 115079.
Crossref
Crossref
Mianli Bian, Ying Sun, Yuanhao Liu, Zhongren Xu, Rong Fan, Ziwen Liu & Wukun Liu. (2020) A Gold(I) Complex Containing an Oleanolic Acid Derivative as a Potential Anti‐Ovarian‐Cancer Agent by Inhibiting TrxR and Activating ROS‐Mediated ERS. Chemistry – A European Journal 26:31, pages 7092-7108.
Crossref
Crossref
Katelyn Dunigan-Russell, Vivian Lin, Mary Silverberg, Stephanie B. Wall, Rui Li, John Gotham, Teodora Nicola, Anusha Sridharan, John Snowball, Cassidy Delaney, Qian Li & Trent E. Tipple. (2020) Aurothioglucose enhances proangiogenic pathway activation in lungs from room air and hyperoxia-exposed newborn mice. American Journal of Physiology-Lung Cellular and Molecular Physiology 318:6, pages L1165-L1171.
Crossref
Crossref
Juan Yao, Dongzhu Duan, Zi-Long Song, Junmin Zhang & Jianguo Fang. (2020) Sanguinarine as a new chemical entity of thioredoxin reductase inhibitor to elicit oxidative stress and promote tumor cell apoptosis. Free Radical Biology and Medicine 152, pages 659-667.
Crossref
Crossref
Yuning Liu, Xiaohui Feng, Yanan Yu, Qingyu Zhao, Chaohua Tang & Junmin Zhang. (2020) A review of bioselenol-specific fluorescent probes: Synthesis, properties, and imaging applications. Analytica Chimica Acta 1110, pages 141-150.
Crossref
Crossref
Sana Waris, Ayyub Patel, Asif Ali & Riaz Mahmood. (2020) Acetaldehyde-induced oxidative modifications and morphological changes in isolated human erythrocytes: an in vitro study. Environmental Science and Pollution Research 27:14, pages 16268-16281.
Crossref
Crossref
Alyssa K. Hartmann, Saketh Gudipati, Andrea Pettenuzzo, Luca Ronconi & Jessica L. Rouge. (2020) Chimeric siRNA-DNA Surfactants for the Enhanced Delivery and Sustained Cytotoxicity of a Gold(III) Metallodrug. Bioconjugate Chemistry 31:4, pages 1063-1069.
Crossref
Crossref
Mirna Jovanović, Daniil Zhukovsky, Ana Podolski-Renić, Raivis Žalubovskis, Dmitry Dar’in, Vladimir Sharoyko, Tatiana Tennikova, Milica Pešić & Mikhail Krasavin. (2020) Further exploration of DVD-445 as a lead thioredoxin reductase (TrxR) inhibitor for cancer therapy: Optimization of potency and evaluation of anticancer potential. European Journal of Medicinal Chemistry 191, pages 112119.
Crossref
Crossref
Ingrid J. Pickering, Qing Cheng, Emérita Mendoza Rengifo, Susan Nehzati, Natalia V. Dolgova, Thomas Kroll, Dimosthenis Sokaras, Graham N. George & Elias S. J. Arnér. (2020) Direct Observation of Methylmercury and Auranofin Binding to Selenocysteine in Thioredoxin Reductase. Inorganic Chemistry 59:5, pages 2711-2718.
Crossref
Crossref
Yu Wang, Wenda Zhang, Junqiang Dong & Jianbo Gao. (2020) Design, synthesis and bioactivity evaluation of coumarin-chalcone hybrids as potential anticancer agents. Bioorganic Chemistry 95, pages 103530.
Crossref
Crossref
Elias S.J. Arnér. 2020. Oxidative Stress. Oxidative Stress
639
667
.
D. B. Korman, E. I. Nekrasova, L. A. Ostrovskaya, O. O. Ryabaya, N. V. Bluhterova & K. A. Abzaeva. (2020) The Sensitivity of Human Tumor Cells to the Cytotoxicity of Gold Polyacrylate (Aurumacryl). Biophysics 64:6, pages 930-935.
Crossref
Crossref
Mirna Jovanović, Daniil Zhukovsky, Ana Podolski-Renić, Ilona Domračeva, Raivis Žalubovskis, Milan Senćanski, Sanja Glišić, Vladimir Sharoyko, Tatiana Tennikova, Dmitry Dar'in, Milica Pešić & Mikhail Krasavin. (2019) Novel electrophilic amides amenable by the Ugi reaction perturb thioredoxin system via thioredoxin reductase 1 (TrxR1) inhibition: Identification of DVD-445 as a new lead compound for anticancer therapy. European Journal of Medicinal Chemistry 181, pages 111580.
Crossref
Crossref
Chuangyu Wen, Huihui Wang, Xiaobin Wu, Lu He, Qian Zhou, Fang Wang, Siyu Chen, Lanlan Huang, Junxiong Chen, Huashe Wang, Weibiao Ye, Wende Li, Xiangling Yang, Huanliang Liu & Junsheng Peng. (2019) ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin. Cell Death & Disease 10:11.
Crossref
Crossref
Gaston OfmanTrent E. Tipple. (2019) Thiol-Redox Regulation in Lung Development and Vascular Remodeling. Antioxidants & Redox Signaling 31:12, pages 858-873.
Crossref
Crossref
Gaston Ofman & Trent E. Tipple. (2019) Antioxidants & bronchopulmonary dysplasia: Beating the system or beating a dead horse?. Free Radical Biology and Medicine 142, pages 138-145.
Crossref
Crossref
Jin-Jing Jia, Wen-Shuo Geng, Zhan-Qi Wang, Lei Chen & Xian-Si Zeng. (2019) The role of thioredoxin system in cancer: strategy for cancer therapy. Cancer Chemotherapy and Pharmacology 84:3, pages 453-470.
Crossref
Crossref
Mianli Bian, Rong Fan, Sai Zhao & Wukun Liu. (2019) Targeting the Thioredoxin System as a Strategy for Cancer Therapy. Journal of Medicinal Chemistry 62:16, pages 7309-7321.
Crossref
Crossref
Salvatore Rizza, Paola Giglio, Fiorella Faienza & Giuseppe Filomeni. 2019. Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders. Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders
173
189
.
Junmin Zhang, Baoxin Zhang, Xinming Li, Xiao Han, Ruijuan Liu & Jianguo Fang. (2019) Small molecule inhibitors of mammalian thioredoxin reductase as potential anticancer agents: An update. Medicinal Research Reviews 39:1, pages 5-39.
Crossref
Crossref
Baoxin Zhang, Yuxin Liu, Xinming Li, Jianqiang Xu & Jianguo Fang. (2018) Small Molecules to Target the Selenoprotein Thioredoxin Reductase. Chemistry - An Asian Journal 13:23, pages 3593-3600.
Crossref
Crossref
Katelyn Dunigan, Qian Li, Rui Li, Morgan L. Locy, Stephanie Wall & Trent E. Tipple. (2018) The thioredoxin reductase inhibitor auranofin induces heme oxygenase-1 in lung epithelial cells via Nrf2-dependent mechanisms. American Journal of Physiology-Lung Cellular and Molecular Physiology 315:4, pages L545-L552.
Crossref
Crossref
Ilaria Silvestri, Haining Lyu, Francesca Fata, Giovanna Boumis, Adriana E. Miele, Matteo Ardini, Rodolfo Ippoliti, Andrea Bellelli, Ajit Jadhav, Wendy A. Lea, Anton Simeonov, Qing Cheng, Elias S. J. Arnér, Gregory R. J. Thatcher, Pavel A. Petukhov, David L. Williams & Francesco Angelucci. (2018) Fragment-Based Discovery of a Regulatory Site in Thioredoxin Glutathione Reductase Acting as “Doorstop” for NADPH Entry. ACS Chemical Biology 13:8, pages 2190-2202.
Crossref
Crossref
Ruijuan Liu, Danfeng Shi, Junmin Zhang, Xinming Li, Xiao Han, Xiaojun Yao & Jianguo Fang. (2018) Xanthatin Promotes Apoptosis via Inhibiting Thioredoxin Reductase and Eliciting Oxidative Stress. Molecular Pharmaceutics 15:8, pages 3285-3296.
Crossref
Crossref
William C. Stafford, Xiaoxiao PengMaria Hägg OlofssonXiaonan ZhangDiane K. Luci, Li LuQing Cheng, Lionel Trésaugues, Thomas S. Dexheimer, Nathan P. Coussens, Martin Augsten, Hanna-Stina Martinsson AhlzénOwe OrwarArne Östman, Sharon Stone-ElanderDavid J. MaloneyAjit Jadhav, Anton SimeonovStig Linder & Elias S. J. Arnér. (2018) Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy. Science Translational Medicine 10:428.
Crossref
Crossref
Junmin Zhang, Xinming Li, Xiao Han, Ruijuan Liu & Jianguo Fang. (2017) Targeting the Thioredoxin System for Cancer Therapy. Trends in Pharmacological Sciences 38:9, pages 794-808.
Crossref
Crossref